You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serotonin Receptor

Showing 1 - 25 of 8,036
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anhedonia Trial (Buspirone 20mg, Placebo comparator)

Not yet recruiting
  • Anhedonia
  • Buspirone 20mg
  • Placebo comparator
  • (no location specified)
Apr 26, 2022

Implication of 5-HT7 Receptor in Inflammatory Mechanisms in

Not yet recruiting
  • Healthy
  • Multiple Sclerosis
  • Blood sample
  • Orléans, France
    CHR Orléans
Feb 16, 2023

Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)

Not yet recruiting
  • Basic Science
  • Lysergic Acid Diethylamide Tartrate
  • Copenhagen, Denmark
    Neurobiology Research Unit, Rigshospitalet
Jul 11, 2023

Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis Trial (Pimavanserin)

Recruiting
  • Neurodegenerative Diseases
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 24, 2023

5-HT7 Receptor Implication in Inflammatory Mechanisms in

Completed
  • Multiple Sclerosis, Acute Relapsing
  • Multiple Sclerosis
  • blood sampling
  • Orléans, France
    CHR Orléans
Feb 16, 2022

Healthy Trial in Basel (Placebo, Mescaline 100mg, Mescaline 200mg)

Recruiting
  • Healthy
  • Placebo
  • +5 more
  • Basel, BS, Switzerland
    University Hospital Basel, Clinical Trial Unit
Aug 17, 2021

Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide

Withdrawn
  • Neuroendocrine Tumors
  • +2 more
  • Telotristat ethyl
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospital and Clinics
Feb 9, 2022

Overweight Trial in Cambridge (Sumatriptan 100 mg)

Not yet recruiting
  • Overweight
  • Sumatriptan 100 mg
  • Cambridge, Cambridgeshire, United Kingdom
    Rajna Golubic
Dec 27, 2020

Depressive Symptoms, Depression, Alzheimer Trial in Baltimore (Psilocybin)

Recruiting
  • Depressive Symptoms
  • +3 more
  • Baltimore, Maryland
    Behavioral Pharmacology Research Unit
Mar 9, 2022

Bipolar Disorder Trial in New York (Fluoxetine, Citalopram)

Completed
Has Results
  • Bipolar Disorder
  • New York, New York
    New York State Psychiatric Institute/Columbia University Medical
Mar 5, 2021

Schizophrenia, Psychosis Trial (Pimavanserin 34 milligrams (MG) [Nuplazid])

Withdrawn
  • Schizophrenia
  • Psychosis
  • Pimavanserin 34 milligrams (MG) [Nuplazid]
  • (no location specified)
Apr 28, 2021

Myofascial Pain, Temporomandibular Disorders Trial in Huddinge (Granisetron, Control ())

Completed
  • Myofascial Pain
  • Temporomandibular Disorders
  • Huddinge, Sweden
    Karolinska Institutet, Department of Dental Medicine
Mar 23, 2021

Schizophrenia Trial in Rockville (Lu AF35700)

Completed
Has Results
  • Schizophrenia
  • Lu AF35700
  • Rockville, Maryland
    US802
May 11, 2020

Constipation Trial (acupuncture, Prucalopride)

Completed
Has Results
  • Constipation
  • (no location specified)
Feb 24, 2021

Peripheral Serotonin and Albinism

Not yet recruiting
  • Oculocutaneous Albinism
  • Dosage of serotonin and metabolites
  • Blood parameters
  • Paris, France
    Hôpital Necker-Enfants Malades
Nov 14, 2023

Carcinoid Heart Disease, Carcinoid Syndrome, Carcinoid Tumor Trial (Lutathera)

Not yet recruiting
  • Carcinoid Heart Disease
  • +2 more
  • (no location specified)
Aug 3, 2020

Depression, Unipolar, Treatment Resistant Depression Trial in Oxford (PF-04995274, Placebo Oral Tablet)

Completed
  • Depression, Unipolar
  • Treatment Resistant Depression
  • Oxford, Oxfordshire, United Kingdom
    University of Oxford
Nov 1, 2022

Tourette Disorder Trial in Bron, Paris (Administration of a PET radiotracer)

Not yet recruiting
  • Tourette Disorder
  • Administration of a PET radiotracer
  • Bron, France
  • +1 more
Jul 12, 2023

Depression, Unipolar Trial in Oxford (PF-04995274, Citalopram, Placebo Oral Tablet)

Completed
  • Depression, Unipolar
  • Oxford, Oxfordshire, United Kingdom
    University of Oxford
Oct 31, 2022

Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)

Not yet recruiting
  • Depression
  • Serotonin Deficiency
  • Pharmacological agent: Citalopram
  • Placebo
  • Kelowna, British Columbia, Canada
    University of British Columbia, Okanagan Campus
Jul 19, 2023

Autism Spectrum Disorder Trial in London (Psilocybin 5 mg, Psilocybin 2 mg, Placebo)

Recruiting
  • Autism Spectrum Disorder
  • Psilocybin 5 mg
  • +2 more
  • London, United Kingdom
    King's College London
Dec 6, 2022

Ischemic Mitral Regurgitation Trial (Cyproheptadine 4 Mg Oral Tablet, Placebo)

Not yet recruiting
  • Ischemic Mitral Regurgitation
  • Cyproheptadine 4 Mg Oral Tablet
  • Placebo
  • (no location specified)
Jul 19, 2022

Intermittent Explosive Disorder Trial in Columbus (Pimavanserin 34 mg, Placebo)

Not yet recruiting
  • Intermittent Explosive Disorder
  • Pimavanserin 34 mg
  • Placebo
  • Columbus, Ohio
    The Ohio State University College of Medicine
May 31, 2023

Study of Specimens Obtained During Epilepsy Surgery

Completed
  • Epilepsy
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 28, 2022

    Depression in Remission Trial in Oxford (Prucalopride, Placebo)

    Recruiting
    • Depression in Remission
    • Oxford, Oxfordshire, United Kingdom
      Department of Psychiatry, Warneford Hospital, University of Oxfo
    Jan 25, 2022